Skip to main content
Clinical Trials/NCT01128413
NCT01128413
Terminated
N/A

Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT)

Washington University School of Medicine1 site in 1 country22 target enrollmentJuly 2010
ConditionsShock

Overview

Phase
N/A
Intervention
Not specified
Conditions
Shock
Sponsor
Washington University School of Medicine
Enrollment
22
Locations
1
Primary Endpoint
Lactate Clearance
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

The short term goal of this study is to evaluate a non-invasive approach that optimizes intravenous (IV) fluid administration according to heart performance and results in surrogate improvements in morbidity and mortality via lactate clearance. Additional objectives include comparative assessments of methods for determining volume responsiveness and establishing a prevalence of volume responsive shock in the Emergency Department (ED).

Detailed Description

Patients will be randomized to Routine Care (RC) or Fluid Optimizations (FO) arms. Both arms will have interval Cheetah NICOM® (non-invasive cardiac output monitoring) Passive Leg Raise Testing (PLRT). In the FO arm, patients having a PLRT demonstrating a \>/= 15% change in stroke volume index (SVI) or cardiac index (CI) patients will receive a 500ml normal saline bolus. If the NICOM® PLRT shows a SVI or CI \<15% patients will receive a saline lock. If bolused, NICOM® PLRT will be performed within 10 minutes after the bolus with the decision to re-bolus or saline lock according to repeated NICOM® PLRT measurements. If saline locked, NICOM® PLRT will be performed every 30 minutes with the decision to re-bolus or saline lock according to repeated NICOM® PLRT measurements. In the RC arm, IV fluid administration will be per the treating clinicians discretion. The Cheetah NICOM®PLRT will be performed before and after each clinician fluid bolus. Lactate blood samples will be drawn at time zero, 1 hour, 3 hours, 6 hours, and/or ED departure and compared between arms.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
November 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christopher Holthaus

MD

Washington University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Hypotension (Systolic Blood Pressure ≤90mm Hg or Mean Arterial Pressure ≤ 65 mm Hg) after ≥ 20ml/kg fluids OR
  • Vasopressor Use OR
  • Lactate ≥ 2.5 mmol/L

Exclusion Criteria

  • Pulse Oximetry \<90% despite supplemental oxygen or intubation
  • Seizure in the last 24 hours
  • Pregnancy
  • Allergy to coupling or ultrasound gel
  • Inability to do passive leg raise
  • Inability to obtain IV access
  • Treating clinician discretion

Outcomes

Primary Outcomes

Lactate Clearance

Time Frame: The median lactate clearance within 6 hours of the ED stay.

The median lactate clearance from time zero to within 6 hours of the ED stay.

Study Sites (1)

Loading locations...

Similar Trials